• Linkedin
  • +1 305 374 2500
  • contact@brandinstitute.com
  • Panel Members
Logo
  • Home
  • About
  • Regulatory Experts
  • Solutions
  • Experience
  • Press Room
  • Contact

Juan Guillen

brandadmin August 29, 2022 0 5 sec read

brandadmin

View More Posts
Previous Article Joe Bazerghi
Next Article Katherine Millan, MST

Leave a Reply Cancel reply

You must be logged in to post a comment.

Part 1: Unique and Unmistakable: Canada’s LASA Testing for Safer Drug Names

Medication errors with medicine giving are among the most avoidable dangers in health care, but they still threaten patient safety […]

December 17, 2024 0 2 min read

Two Brands, One Drug: The Potential Benefits and Challenges of Dual Branding

Dual branding in the pharmaceutical industry refers to a marketing strategy where a single product is marketed under two different […]

April 6, 2023 0 2 min read

ANVISA: The Most Mature Pharmaceutical Regulatory System in Latin America

The Brazilian regulatory Agency, Anvisa (Agência Nacional de Vigilância Sanitária) issues market authorizations for medical devices and pharmaceuticals; exercises post-marketing […]

April 13, 2023 0 3 min read

Naming Strategies in Pharmaceutical Brand Name Development

One of the questions I am often asked about pharmaceutical brand naming is, “Where do you start?” The public, and […]

August 21, 2020 0 2 min read
  • Careers
  • Panel Members
  • Privacy Policy

Copyright © 2025 Brand Institute. All rights reserved.
All trademarks and images are the property of their respective owners.